{"id":"W4409518994","doi":"10.1111/ene.70158","title":"Long‐Term Efficacy and Safety of Ravulizumab in Adults With Anti‐Acetylcholine Receptor Antibody‐Positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open‐Label Extension","year":2025,"lang":"en","type":"article","venue":"European Journal of Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; University of Toronto; London Health Sciences Centre","funders":"Alexion Pharmaceuticals; AstraZeneca","keywords":"Myasthenia gravis; Medicine; Placebo; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004092542,0.0004896029,0.0008598816,0.0001502827,0.0002425603,0.0005066941,0.0003267216,0.000544787,0.001005361],"category_scores_gemma":[0.001907253,0.0001757447,0.0008656308,0.0001461033,0.0003380506,0.0004816878,0.0002902414,0.001131916,0.0002173205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005508977,"about_ca_system_score_gemma":0.0006704998,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005158106,"about_ca_topic_score_gemma":0.00117152,"domain_scores_codex":[0.9992494,0.0003599723,0.00006260959,0.00007944494,0.0001430373,0.000105453],"domain_scores_gemma":[0.9987147,0.0003074885,0.0005580778,0.0000723713,0.0001147234,0.000232521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5044808,0.01502393,0.08282089,0.001340391,0.002881528,0.0004881239,0.0008744946,0.001819532,0.05489498,0.0002463058,0.004510993,0.330618],"study_design_scores_gemma":[0.1609106,0.4561847,0.363274,0.0002183271,0.002152319,0.001025972,0.0001618629,0.001478878,0.008392238,0.0001949245,0.005938077,0.00006815792],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945668,0.003877081,0.0002132978,0.0001786296,0.00001986989,0.0002788692,0.0002654982,0.00002006431,0.0005798988],"genre_scores_gemma":[0.9974391,0.0007849042,0.0004640679,0.0002240053,0.00005912488,0.0002138829,0.0004581983,0.00000523526,0.0003514571],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004092542,"threshold_uncertainty_score":0.0216437,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0267167186454999,"score_gpt":0.318157775286445,"score_spread":0.2914410566409451,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}